Osher Van de Voorde Investment Management lessened its holdings in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 0.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 116,180 shares of the e-commerce giant’s stock after selling 240 shares during the quarter. Amazon.com makes up approximately 4.7% of Osher Van de Voorde Investment Management’s holdings, making the stock its 3rd biggest holding. Osher Van de Voorde Investment Management’s holdings in Amazon.com were worth $21,648,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in AMZN. Garrison Point Advisors LLC raised its stake in Amazon.com by 0.3% in the 1st quarter. Garrison Point Advisors LLC now owns 20,375 shares of the e-commerce giant’s stock valued at $3,675,000 after acquiring an additional 55 shares during the period. Meridian Investment Counsel Inc. raised its position in shares of Amazon.com by 1.8% in the second quarter. Meridian Investment Counsel Inc. now owns 3,076 shares of the e-commerce giant’s stock valued at $594,000 after buying an additional 55 shares in the last quarter. Stordahl Capital Management Inc. lifted its position in shares of Amazon.com by 2.1% during the 1st quarter. Stordahl Capital Management Inc. now owns 2,763 shares of the e-commerce giant’s stock valued at $498,000 after acquiring an additional 56 shares during the period. Lutz Financial Services LLC grew its stake in Amazon.com by 1.9% during the first quarter. Lutz Financial Services LLC now owns 3,053 shares of the e-commerce giant’s stock worth $551,000 after buying an additional 57 shares in the last quarter. Finally, O Dell Group LLC increased its stake in Amazon.com by 0.4% in the first quarter. O Dell Group LLC now owns 13,638 shares of the e-commerce giant’s stock valued at $2,460,000 after acquiring an additional 57 shares during the last quarter. 72.20% of the stock is currently owned by institutional investors.
Amazon.com Stock Performance
NASDAQ:AMZN opened at $195.78 on Tuesday. Amazon.com, Inc. has a 52-week low of $138.36 and a 52-week high of $201.20. The firm has a market cap of $2.05 trillion, a price-to-earnings ratio of 41.92, a PEG ratio of 1.42 and a beta of 1.14. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.88 and a current ratio of 1.10. The business’s fifty day moving average is $185.23 and its 200 day moving average is $183.89.
Insiders Place Their Bets
In other news, CEO Andrew R. Jassy sold 20,784 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $180.77, for a total value of $3,757,123.68. Following the completion of the sale, the chief executive officer now owns 2,056,534 shares of the company’s stock, valued at approximately $371,759,651.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP David Zapolsky sold 9,490 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $180.88, for a total transaction of $1,716,551.20. Following the completion of the transaction, the senior vice president now owns 64,610 shares in the company, valued at $11,686,656.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Andrew R. Jassy sold 20,784 shares of Amazon.com stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $180.77, for a total transaction of $3,757,123.68. Following the sale, the chief executive officer now directly owns 2,056,534 shares in the company, valued at $371,759,651.18. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,855 shares of company stock valued at $9,215,048 over the last 90 days. Insiders own 10.80% of the company’s stock.
Wall Street Analyst Weigh In
AMZN has been the topic of several research reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Amazon.com from $225.00 to $232.00 and gave the company a “buy” rating in a report on Friday. JMP Securities increased their target price on shares of Amazon.com from $265.00 to $285.00 and gave the company a “market outperform” rating in a research report on Friday. Piper Sandler boosted their price objective on Amazon.com from $215.00 to $225.00 and gave the company an “overweight” rating in a research note on Friday. TD Cowen lifted their price target on shares of Amazon.com from $230.00 to $240.00 and gave the company a “buy” rating in a research note on Friday. Finally, TD Securities lifted their price target on shares of Amazon.com from $225.00 to $245.00 in a research report on Wednesday, July 10th. Two equities research analysts have rated the stock with a hold rating, forty have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $246.48.
Read Our Latest Research Report on AMZN
Amazon.com Company Profile
Amazon.com, Inc engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content.
Featured Articles
- Five stocks we like better than Amazon.com
- The How And Why of Investing in Oil Stocks
- Intel: Is Now the Time to Be Brave?Â
- What is the Nasdaq? Complete Overview with History
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Stocks to Consider Buying in October
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.